| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vp/ Chief Accounting Officer | See Remarks
1 company
Chopas James George is a Vp/ Chief Accounting Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $2.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 22, 2024 | APLS Apellis Pharmaceuticals, Inc. | Vp/ Chief Accounting Officer | Sell | 1,061 | $65.00 | $68,960.76 | -2.6% | -27.2% | -54.0% | |
| Jan 16, 2024 | APLS Apellis Pharmaceuticals, Inc. | Vp/ Chief Accounting Officer | Sell | 864 | $66.81 | $57,722.63 | -2.1% | -22.3% | -56.2% | |
| Oct 23, 2023 | APLS Apellis Pharmaceuticals, Inc. | Vp/ Chief Accounting Officer | Sell | 132 | $46.04 | $6,076.78 | -0.4% | +44.2% | -39.2% | |
| Aug 31, 2023 | APLS Apellis Pharmaceuticals, Inc. | Vp/ Chief Accounting Officer | Sell | 551 | $41.23 | $22,715.53 | -1.8% | +19.2% | -7.8% |